Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-07T09:03:25.913Z Has data issue: false hasContentIssue false

Immunological underpinnings of Ascaris infection, reinfection and co-infection and their associated co-morbidities

Published online by Cambridge University Press:  12 April 2021

Luisa Magalhães
Affiliation:
Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Denise S. Nogueira
Affiliation:
Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Pedro H. Gazzinelli-Guimarães
Affiliation:
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA
Fabricio M. S. Oliveira
Affiliation:
Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Lucas Kraemer
Affiliation:
Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Ana Clara Gazzinelli-Guimarães
Affiliation:
Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Flaviane Vieira-Santos
Affiliation:
Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Ricardo T. Fujiwara
Affiliation:
Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Lilian L. Bueno*
Affiliation:
Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
*
Author for correspondence: Lilian L. Bueno, E-mail: fujiwara@icb.ufmg.br and llbueno@icb.ufmg.br

Abstract

Human ascariasis is the most common and prevalent neglected tropical disease and is estimated that ~819 million people are infected around the globe, accounting for 0.861 million years of disability-adjusted life years in 2017. Even with the existence of highly effective drugs, the constant presence of infective parasite eggs in the environment contribute to a high reinfection rate after treatment. Due to its high prevalence and broad geographic distribution Ascaris infection is associated with a variety of co-morbidities and co-infections. Here, we provide data from both experimental models and humans studies that illustrate how complex is the interaction of Ascaris with the host immune system, especially, in the context of reinfections, co-infections and associated co-morbidities.

Information

Type
Review Article
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press
Figure 0

Fig. 1. Ascaris reinfection. Figure compiles the data obtained from the different experimental model for 1 or multiple infections with A. suum. In the lungs, repeated infection leads to higher lung inflammation and cellularity with increase number and activation status of neutrophils, eosinophils, lymphocytes and macrophages. Nevertheless, reinfected animals display lower larvae burden, less haemorrhage and pulmonary impairment. Necropsy also evidenced a reduction in the number of milk spots in the liver from reinfected animals. In the intestine, reinfected animals show an increase in number and activation status of eosinophils, mastocytes and goblet cells with higher expression of IL-13 that leads to increased contractility and mucus secretion. All those factors culminate with lower L4/young adult's larvae. The prolonged infection has been shown to induce the generation of specific antibodies to the parasite, with a predominance of IgG1 and IgA, while recent primary infection generates polyreactive IgG1, IgG3 and IgE. The cytokine response also differs from single to reinfection models. With a predominance of a Th2/Th17 response in the latter compared to Th1/Th2 phenotype in primo-infected animals.

Figure 1

Fig. 2. Pulmonary fibrosis. The association of previous pulmonary fibrosis and A. suum infection increases lung damage, characterized by an increase in exudative phenomena and haemorrhage induced by larval migration. The presence of A. suum in pulmonary parenchyma that already present fibrosis increased the expression of IL-1, IL-4, IL-6, IL-13, IL-17A, IL-33 and TGF-β1 cytokines. Despite the increase in the expression of cytokines with a profibrogenic profile during comorbidity, this did not contribute to the worsening of lung fibrosis. Larval migration is not impaired by pulmonary fibrosis. The success of the loss cycle in comorbidity occurs due to A. suum larvae migration non-fibrous areas in the lung parenchyma.